NCT05658536Completed
The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19
The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID
Source: ClinicalTrials.gov · Last updated 29 Mar 2024
Brief summary (registry, in English)
This project is a randomized controlled pilot trial using mixed methods to examine the feasibility, acceptability, and initial effects of a telemedicine group-based intervention designed to improve symptom management and coping in adults with Post-COVID.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 51 (actual)
- First submitted
- 16 Dec 2022
- Start date
- 18 Jan 2023
- Primary completion date
- 30 Jan 2024
- Lead sponsor
- University of Washington
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05658536
What you commit to
- Study type: Interventional
- Participants enrolled: 51
- From 18 Jan 2023 to the primary completion date, 30 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving other psychosocial treatments primarily for any Post-COVID symptom(s) or problem(s)
Other illness
- Severe cognitive impairment
Who the study is looking for
- Age ≥ 18 years
- Resident of Washington state
- Diagnosis of a Post-COVID condition
- Able to read, speak, and understand English
- Availability of a telephone and internet access
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Washington, Ninth and Jefferson Building Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.